• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Executive Chairman Constable David E sold $2,005,972 worth of shares (40,000 units at $50.15), decreasing direct ownership by 5% to 830,627 units (SEC Form 4)

    6/17/25 4:30:21 PM ET
    $FLR
    Military/Government/Technical
    Industrials
    Get the next $FLR alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    X
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Constable David E

    (Last) (First) (Middle)
    C/O FLUOR CORPORATION
    6700 LAS COLINAS BLVD

    (Street)
    IRVING TX 75039

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    FLUOR CORP [ FLR ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    Executive Chairman
    3. Date of Earliest Transaction (Month/Day/Year)
    06/16/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 06/16/2025 S(1) 40,000 D $50.1493(2) 830,627 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 16, 2024.
    2. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.35, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
    /s/ Eric P. Helm by Power of Attorney 06/17/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $FLR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $FLR

    DatePrice TargetRatingAnalyst
    12/18/2024$54.00 → $58.00Outperform → Neutral
    Robert W. Baird
    10/22/2024$52.00 → $65.00Neutral → Buy
    Citigroup
    7/17/2024$57.00Sector Weight → Overweight
    KeyBanc Capital Markets
    3/14/2024$46.00Buy
    Truist
    1/10/2024Sector Weight
    KeyBanc Capital Markets
    10/4/2023$35.00 → $47.00Neutral → Buy
    UBS
    11/7/2022$25.00 → $40.00Neutral → Buy
    DA Davidson
    2/23/2022$30.00 → $29.00Neutral → Outperform
    Robert W. Baird
    More analyst ratings

    $FLR
    SEC Filings

    See more
    • SEC Form SD filed by Fluor Corporation

      SD - FLUOR CORP (0001124198) (Filer)

      6/2/25 4:34:19 PM ET
      $FLR
      Military/Government/Technical
      Industrials
    • Amendment: SEC Form SCHEDULE 13G/A filed by Fluor Corporation

      SCHEDULE 13G/A - FLUOR CORP (0001124198) (Subject)

      5/12/25 10:44:45 AM ET
      $FLR
      Military/Government/Technical
      Industrials
    • Amendment: SEC Form SCHEDULE 13G/A filed by Fluor Corporation

      SCHEDULE 13G/A - FLUOR CORP (0001124198) (Subject)

      5/12/25 10:32:18 AM ET
      $FLR
      Military/Government/Technical
      Industrials

    $FLR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Executive Chairman Constable David E sold $2,005,972 worth of shares (40,000 units at $50.15), decreasing direct ownership by 5% to 830,627 units (SEC Form 4)

      4 - FLUOR CORP (0001124198) (Issuer)

      6/17/25 4:30:21 PM ET
      $FLR
      Military/Government/Technical
      Industrials
    • Executive Chairman Constable David E sold $1,999,343 worth of shares (40,800 units at $49.00), decreasing direct ownership by 4% to 870,627 units (SEC Form 4)

      4 - FLUOR CORP (0001124198) (Issuer)

      6/12/25 5:49:22 PM ET
      $FLR
      Military/Government/Technical
      Industrials
    • GROUP PRESIDENT Collins Alvin C Iii sold $859,536 worth of shares (18,920 units at $45.43), decreasing direct ownership by 23% to 64,383 units (SEC Form 4)

      4 - FLUOR CORP (0001124198) (Issuer)

      6/10/25 4:53:26 PM ET
      $FLR
      Military/Government/Technical
      Industrials

    $FLR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Fluor-Built Pharmaceutical Facility in California is First Industrial Manufacturing Facility in Western United States to Achieve LEED v4 Platinum Certification

      Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs Fluor Corporation (NYSE:FLR) announced today that Bayer's Cell Therapy Launch Facility in Berkeley, California, has been designated the first industrial manufacturing facility in the Western United States to achieve Leadership in Energy and Environmental Design (LEED) v4 Platinum Certification. The project was also named the 2025 Facility of the Year for Social Impact - Unmet Medical Needs by the International Society for Pharmaceutical Engineering (ISPE). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250519864245/en/Bayer's Cell T

      5/19/25 7:19:00 AM ET
      $FLR
      Military/Government/Technical
      Industrials
    • Fluor Reports First Quarter 2025 Results

      "Grow and execute" chapter of Fluor's strategy launched Q1 revenue book to burn ratio of 1.5x Accelerated Q1 share repurchases of $142 million; targeting $600 million in repurchases for 2025 Company maintains 2025 guidance Fluor Corporation (NYSE:FLR) announced financial results for its first quarter ended March 31, 2025. "We are well positioned for the grow and execute chapter of our Building a Better Future strategy. As we continue to deliver on our projects and take in quality backlog, we see substantial opportunities for growth in our key markets. Our businesses are focused on organic growth and our core competencies will deliver results that support our customers' needs," sai

      5/2/25 5:50:00 AM ET
      $FLR
      Military/Government/Technical
      Industrials
    • Fluor to Participate in Upcoming Investor Conferences

      Fluor Corporation (NYSE:FLR) announced today that management will be hosting one on one meetings at the following conferences for the second quarter of 2025: May 8: Truist Securities Industrials & Services Conference – John Regan, Chief Financial Officer and Jason Landkamer, Vice President, Investor Relations. May 28: KeyBanc Industrials & Basic Materials Conference - Jim Breuer, Chief Executive Officer will be joining John Regan, Chief Financial Officer and Jason Landkamer, Vice President, Investor Relations. June 4: Baird Global Consumer, Technology & Services Conference – Steve Hopkins, Sr. Vice President of Advanced Technologies & Life Sciences will be joining Jason Landkamer, Vic

      4/30/25 8:00:00 AM ET
      $FLR
      Military/Government/Technical
      Industrials

    $FLR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Fluor downgraded by Robert W. Baird with a new price target

      Robert W. Baird downgraded Fluor from Outperform to Neutral and set a new price target of $58.00 from $54.00 previously

      12/18/24 7:34:35 AM ET
      $FLR
      Military/Government/Technical
      Industrials
    • Fluor upgraded by Citigroup with a new price target

      Citigroup upgraded Fluor from Neutral to Buy and set a new price target of $65.00 from $52.00 previously

      10/22/24 6:16:21 AM ET
      $FLR
      Military/Government/Technical
      Industrials
    • Fluor upgraded by KeyBanc Capital Markets with a new price target

      KeyBanc Capital Markets upgraded Fluor from Sector Weight to Overweight and set a new price target of $57.00

      7/17/24 7:35:40 AM ET
      $FLR
      Military/Government/Technical
      Industrials